20.4 C
New York
Thursday, June 18, 2026

Tag: intellectual property

newssourceFORcompanyinformationcontent1marketreleases

Saks Global Announces Early Settlement of the Exchange Offer and Consent Solicitation, Completing Previously Announced $600 Million Financing Package

Company received $300 million in connection with the Exchange Offer on August 8, 2025 Holders of approximately 98% of the aggregate principal amount of the...

Capricor Therapeutics Announces Type A Meeting Scheduled with U.S. FDA

– Second Quarter 2025 Financial Results and Corporate Update Rescheduled to Monday, August 11, 2025, at 4:30 p.m. ET – 
– Second Quarter 2025 Financial Results and Corporate Update Rescheduled to Monday, August 11, 2025, at 4:30 p.m. ET –

KOPPERS REPORTS SECOND QUARTER 2025 RESULTS; REVISES 2025 OUTLOOK

Sales of $504.8 Million vs. $563.2 Million in Prior Year QuarterNet income attributable to Koppers of $16.4 Million vs. $26.8 Million in Prior Year...

THE WENDY’S COMPANY REPORTS SECOND QUARTER 2025 RESULTS

Global systemwide sales were $3.7 billion, a decrease of 1.8%International systemwide sales grew 8.7% with growth across all regionsAdded 26 net new restaurants and...

SIR Royalty Income Fund Reports 2025 Second Quarter Financial Results

BURLINGTON, ON, Aug. 7, 2025 /CNW/ - SIR Royalty Income Fund (TSX: SRV.UN) (the "Fund") today reported its financial results for the second quarter...

Post Holdings Reports Results for the Third Quarter of Fiscal Year 2025; Raises Fiscal Year 2025 Outlook

ST. LOUIS, Aug. 7, 2025 /PRNewswire/ -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the third fiscal quarter...

AKAMAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

Second quarter revenue of $1.043 billion, up 7% year-over-year and up 6% when adjusted for foreign exchange* Cloud Infrastructure Services** revenue of $71 million, up 30% year-over-year...

Sports.com Studios and GOATS Entertainment Forge Strategic Partnership to Monetize Iconic Sports IP

A Media Snippet accompanying this announcement is available by clicking on this link.

Worksport ($WKSP) Issues Corporate Update: Bitcoin Holdings Double, Production Capacity Scales, New Automotive OEM Discussions, and Brand Visibility Initiatives

Strong Growth in Business Fundamentals, Increased Brand Visibility, and New Strategic Conversations Signal Continued Momentum into Q3 and Q4 2025

Lilly reports second-quarter 2025 financial results and raises guidance

Revenue in Q2 2025 increased 38% to $15.56 billion driven by volume growth from Zepbound and Mounjaro. Increased the midpoint of our 2025 full-year...

Primo Brands Reports Second Quarter 2025 Results

Revises full year 2025 Net Sales, Adjusted EBITDA, and Adjusted Free Cash Flow guidanceReaffirms cost synergy capture targets of $200 million in 2025; $300...

Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results

Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of 2025 Initiated ALKAZAR...

accesso® and Six Flags Extend 20-Year Ticketing Partnership with New 5-Year eCommerce Agreement

accesso Technology to Support Growth and Guest Experience Across 42 Six Flags Venues in North America TWYFORD, England, Aug. 7, 2025 /CNW/ -- accesso Technology Group (AIM: ACSO),...

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information

Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and older and has approved updates to the Prescribing Information (PI) for IXCHIQ®. IXCHIQ® remains indicated in the United States for the prevention of disease caused by the Chikungunya Virus (CHIKV) in individuals 18 years of age and older who are at high risk of exposure to CHIKV.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsIntellectual property

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers